NCIMB has joined forces with scientists at Robert Gordon University (RGU) to screen Streptomyces species for the production of novel natural products that have potential for use in pharmaceuticals such as antimicrobials, anti-tumour or anti-inflammatory medication, as well as compounds relevant to other industry sectors. Bacteria are used to manufacture a wide range of important products, including antibiotics and other medicines. NCIMB’s culture collection – The National Collection of Industrial Food and Marine Bacteria – includes more than 10,000 different microbes and has great potential as a source of valuable new …
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Read our Privacy Policy and website Terms and Conditions.